PropertyValue
?:abstract
  • Considering the recent controversies regarding the use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Coronavirus disease 2019 (COVID-19) patients, and due to the limited published data in this field, we reviewed currently available evidence for the use of NSAIDs in viral respiratory tract infections to help make decisions in this area Currently, there is insufficient evidence to judge the safety and efficacy of NSAIDs in patients with COVID-19 According to the current evidence, acetaminophen is the choice treatment for symptomatic relief If the patients\' symptoms are not controlled by acetaminophen, naproxen may be used as an alternative therapy © 2020 The Author(s) This is an open access article and applies the Creative Commons Attribution License (http://creativecommons org/licenses/by-nc/4 0/), which permits unrestricted use, distribution, and reproduction in any medium, as long as the original authors and source are cited
is ?:annotates of
?:creator
?:journal
  • Pharmaceutical_Sciences
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • NSAIDs and COVID-19: A new challenging area
?:type
?:who_covidence_id
  • #971423
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/pifdu8a3>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/pifdu8a3>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all